BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16254244)

  • 1. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
    Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
    J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K9 acetylation and radial chromatin positioning.
    Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
    J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.
    Taddei A; Maison C; Roche D; Almouzni G
    Nat Cell Biol; 2001 Feb; 3(2):114-20. PubMed ID: 11175742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
    Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin.
    Tóth KF; Knoch TA; Wachsmuth M; Frank-Stöhr M; Stöhr M; Bacher CP; Müller G; Rippe K
    J Cell Sci; 2004 Aug; 117(Pt 18):4277-87. PubMed ID: 15292402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.
    Nielsen AL; Ortiz JA; You J; Oulad-Abdelghani M; Khechumian R; Gansmuller A; Chambon P; Losson R
    EMBO J; 1999 Nov; 18(22):6385-95. PubMed ID: 10562550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A.
    Galiová G; Bártová E; Raska I; Krejcí J; Kozubek S
    Eur J Cell Biol; 2008 May; 87(5):291-303. PubMed ID: 18396346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy.
    Allison SJ; Milner J
    Cancer Res; 2003 Oct; 63(20):6674-9. PubMed ID: 14583461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
    Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
    Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V; Breuzard G; Fourré N; Dufer J
    Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-dependent redistributions of acetylated histones in nuclei of the early preimplantation mouse embryo.
    Stein P; Worrad DM; Belyaev ND; Turner BM; Schultz RM
    Mol Reprod Dev; 1997 Aug; 47(4):421-9. PubMed ID: 9211426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation.
    Pollack BP; Sapkota B; Boss JM
    Photochem Photobiol; 2009; 85(3):652-62. PubMed ID: 19076306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
    Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.